VICTORY CAPITAL MANAGEMENT INC
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1040188
San Antonio, TX
Position in LXRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$58,135
+$22,756 QoQ
Shares Held
24,223
+6.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 149 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. LXRX ranks #134 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in LXRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,135 | 24,223 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $35,379 | 22,679 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,369 | 21,191 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,381 | 21,023 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $20,059 | 21,115 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,951 | 21,633 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $15,435 | 20,859 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $69,561 | 44,307 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $76,172 | 45,341 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $75,285 | 31,369 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $49,246 | 32,187 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $28,747 | 26,374 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $46,374 | 20,251 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $50,356 | 20,723 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $39,007 | 20,423 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $49,039 | 20,433 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $21,501 | 11,560 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $24,208 | 11,583 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $110,126 | 27,951 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $100,841 | 20,965 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $49,080 | 10,693 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $59,375 | 10,115 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $42,154 | 12,326 | Shares | Sole | 2021-02-01 | |
| 2020-03-31 | $105,237 | 53,968 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||